BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 23394975)

  • 41. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An acute pharyngeal-cervical-brachial (PCB) variant of Guillain-Barre syndrome presenting with isolated bulbar palsy.
    Hamidon BB
    Med J Malaysia; 2006 Jun; 61(2):245-7. PubMed ID: 16898323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Finger drop sign" in Guillain-Barré syndrome.
    George A; Abdurehiman P; James J
    Neurol India; 2009; 57(3):282-6. PubMed ID: 19587468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The refractory period of transmission is impaired in axonal Guillain-Barré syndrome.
    Kuwabara S; Bostock H; Ogawara K; Sung JY; Kanai K; Mori M; Hattori T; Burke D
    Muscle Nerve; 2003 Dec; 28(6):683-9. PubMed ID: 14639581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guillain-Barré syndrome during childhood: particular clinical and electrophysiological features.
    Devos D; Magot A; Perrier-Boeswillwald J; Fayet G; Leclair-Visonneau L; Ollivier Y; Nguyen The Tich S; Pereon Y
    Muscle Nerve; 2013 Aug; 48(2):247-51. PubMed ID: 23813561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensory nerves are frequently involved in the spectrum of fisher syndrome.
    Shahrizaila N; Goh KJ; Kokubun N; Tan AH; Tan CY; Yuki N
    Muscle Nerve; 2014 Apr; 49(4):558-63. PubMed ID: 23893512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Significance of Serial Nerve Conduction in GB Syndrome.
    Kalita J; Kumar M; Misra UK
    Neurol India; 2022; 70(5):1995-2002. PubMed ID: 36352600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversible conduction failure in pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
    Capasso M; Notturno F; Manzoli C; Yuki N; Uncini A
    Muscle Nerve; 2010 Oct; 42(4):608-12. PubMed ID: 20878742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conduction velocity distribution in neurologically well-recovered but fatigued Guillain-Barré syndrome patients.
    Garssen MP; Blok JH; van Doorn PA; Visser GH
    Muscle Nerve; 2006 Feb; 33(2):177-82. PubMed ID: 16270305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serial peripheral nerve ultrasound in Guillain-Barré syndrome.
    Razali SNO; Arumugam T; Yuki N; Rozalli FI; Goh KJ; Shahrizaila N
    Clin Neurophysiol; 2016 Feb; 127(2):1652-1656. PubMed ID: 26228791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological measurement at Erb's point during the early stage of Guillain-Barré syndrome.
    Ye Y; Zhu D; Liu L; Wang K; Huang K; Hou C
    J Clin Neurosci; 2014 May; 21(5):786-9. PubMed ID: 24412297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.
    Nedkova V; Gutiérrez-Gutiérrez G; Navacerrada-Barrero FJ; Berciano J; Casasnovas C
    Acta Neurol Belg; 2021 Oct; 121(5):1141-1150. PubMed ID: 33599939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: an analysis of 142 cases.
    Gupta D; Nair M; Baheti NN; Sarma PS; Kuruvilla A;
    J Clin Neuromuscul Dis; 2008 Dec; 10(2):42-51. PubMed ID: 19169089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Admission neurophysiological abnormalities in Guillain-Barré syndrome: A single-center experience.
    Luigetti M; Servidei S; Modoni A; Rossini PM; Sabatelli M; Lo Monaco M
    Clin Neurol Neurosurg; 2015 Aug; 135():6-10. PubMed ID: 26001516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phrenic nerve CMAP amplitude, duration, and latency could predict respiratory failure in Guillain-Barre syndrome.
    Basiri K; Dashti M; Haeri E
    Neurosciences (Riyadh); 2012 Jan; 17(1):57-60. PubMed ID: 22246012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: Criteria sets and sparse linear discriminant analysis.
    Uncini A; Ippoliti L; Shahrizaila N; Sekiguchi Y; Kuwabara S
    Clin Neurophysiol; 2017 Jul; 128(7):1176-1183. PubMed ID: 28521265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sensorineural deafness in Guillain-Barré syndrome].
    Ueda N; Kuroiwa Y
    Brain Nerve; 2008 Oct; 60(10):1181-6. PubMed ID: 18975606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of sensory nerve conduction studies in the diagnosis of Guillain-Barré syndrome.
    Freiha J; Zoghaib R; Makhoul K; Maalouf N; Riachi N; Chalah MA; Ayache SS; Ahdab R
    Clin Neurophysiol; 2021 May; 132(5):1157-1162. PubMed ID: 33780722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.